All News

The findings demonstrate why quality ratings focus heavily on managing diabetes and targeting 30-day readmission rates.

This post is part of a series of blogs illuminating aspects of racial equity in childbirth and highlighting promising practices to ensure access to a safe, empowering, healthy, and positive birth for all people.

The Government Accountability Office (GAO) recommended that CMS should take steps to prevent lower quality hospitals from qualifying for value-based bonuses, after a report by the office found that some bonuses in recent years had rewarded poorly-rated hospitals.

The incidence of multiply recurrent Clostridium difficile infection is increasing in the United States, leading to a higher demand for new treatments, according to a recent study.

Research published by Cancer Management & Research explores the efficacy of treating multiple malignancies with immune checkpoint inhibitors and programmed cell death-1 inhibitors (PD-1). The review specifically analyzes the presence of pneumonitis as an adverse event following treatment of checkpoint inhibitors.

Narrow insurance coverage has forced some patients to choose between lower premium plans and access to better quality cancer care, according to a recent report.

A study published by BloodAdvances, a Journal of the American Society of Hematology, demonstrated the potential of the 2-pronged approach in treating non-Hodgkin lymphoma, multiple myeloma, and acute myeloid leukemia.

New results from a meta-analysis reveal a decrease in the excess risk of cardiovascular events in patients with rheumatoid arthritis (RA) since the start of the 21st century.

The FDA has approved the Praxis Extended RAS Panel for genetic testing in patients with metastatic colorectal cancer (CRC). Detecting certain tumor mutations using the test could have important implications for treatment decisions.

Patients with chronic obstructive pulmonary disease (COPD) often experience chronic pain symptoms, including low physical activity, depression, and hyperinflation, that impact their everyday lives.

Biosimilar molecules have gained access to the US market, and providers and patients are steadily warming up to the idea of using these products, but challenges still exist. Here are 5 of the recent developments in the biosimilar landscape.

Treating myelodysplastic syndrome patients with luspatercept can increase hemoglobin and decrease the burden of red blood cell transfusion for more than 26 months, according to new results from a phase 2 trial.

This week, the top managed care news included Senators hearing from their constituents about the healthcare bill; a dispute with a health insurer shut down a state government for 3 days; and the FDA approved a new test for leukemias and lymphomas.

Patients with schizophrenia are at high risk of developing diabetes, particularly due to the effects of antipsychotic medications, but the results of a recently published trial indicate liraglutide can help improve glucose tolerance and body weight in prediabetic patients.

Minnesota's attorney general helped resolve a split that was a sign of the times. Top-performing hospitals increasingly find themselves on the outside of narrow networks when managed care contracts try to limit costs.

The FDA has placed 3 clinical trials of Keytruda (pembrolizumab) on hold in response to a pattern of patient deaths, according to a statement from Merck.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

There is limited evidence connecting depression to the disease course of inflammatory bowel disease, according to a new study. However, Crohn's disease had a strong association.

The BreathLink device is intended to immediately identify any indications of breast cancer based on a 2-minute sample of a patient’s breath.

Lawmakers had ordered Kasich to start the process of undoing Medicaid expansion, but the Republican governor vetoed the budget language.

Stanford Medicine recently published its first annual Health Trends Report, revealing the prominence of big data and the potential difficulties it can produce when attempting to improve the healthcare system.

A phase 3 trial in patients with advanced melanoma found that nivolumab (Opdivo) outperformed ipilimumab (Yervoy) in terms of recurrence-free survival.

The trials appearing in JAMA found insulin degludec showed even stronger benefits in helping avoid hypoglycemia at night, which is always a concern for those with diabetes.

From 2011 to 2014 the use of high-intensity statins following hospitalization for myocardial infarction (MI) increased progressively, according to a study published in Journal of the American College of Cardiology.

Advanced radiotherapy treatment, combined with chemotherapy, in small cell lung cancer leads to higher survival rates and lower toxicity, according to a new study.

A collaborative research study, based on survey results gathered by the American Cancer Society, has found a correlation between depressive symptoms in cancer caregivers and a decline in their physical health.

The interventions sought to affect both health metrics and behavior, according to the papers appearing in the journal Obesity.